Home » Stocks » PGNY

Progyny, Inc. (PGNY)

Stock Price: $56.60 USD 0.49 (0.87%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
After-hours: $56.35 -0.25 (-0.44%) Jul 23, 5:47 PM
Market Cap 5.01B
Revenue (ttm) 385.97M
Net Income (ttm) 57.57M
Shares Out 88.53M
EPS (ttm) 0.58
PE Ratio 97.42
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $56.60
Previous Close $56.11
Change ($) 0.49
Change (%) 0.87%
Day's Open 56.22
Day's Range 55.26 - 56.89
Day's Volume 560,117
52-Week Range 23.56 - 66.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...

2 days ago - GlobeNewsWire

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

2 days ago - Zacks Investment Research

APPS, QFIN, PGNY, and SSP have qualified the screen for high net income ratio stocks.

Other stocks mentioned: APPS, QFIN, SSP
5 days ago - Zacks Investment Research

Progyny (PGNY) has been struggling lately, but the selling pressure may be coming to an end soon.

1 week ago - Zacks Investment Research

Despite the strong rally in U.S. stocks, there has been volatility too. Here are the seven best stock charts that could spell more upside.

Other stocks mentioned: AAPL, AMZN, DIA, HD, SBUX
2 weeks ago - InvestorPlace

Progyny, Inc (NASDAQ: PGNY) shares have advanced more than  40% since the beginning of January 2021, and the current share price stands around $59. Progyny expects adjusted EBITDA between $70 million to...

1 month ago - Invezz

Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 month ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in Progyny, Inc. (PGNY)

1 month ago - Zacks Investment Research

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...

1 month ago - GlobeNewsWire

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

1 month ago - Zacks Investment Research

Progyny (PGNY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "R...

1 month ago - Zacks Investment Research

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, alon...

1 month ago - GlobeNewsWire

DENVER, May 19, 2021 /PRNewswire/ -- Family planning and fertility benefits are becoming more mainstream with employers seeking to demonstrate inclusivity and attract or retain talent. As women become m...

2 months ago - PRNewsWire

NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, toda...

2 months ago - GlobeNewsWire

Progyny (PGNY) delivered earnings and revenue surprises of 87.50% and 0.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Reports Record First Quarter Revenue of $122.1 Million, Reflecting 51% GrowthIssues Revenue Guidance of $126.0 to $131.0 Million for the Second Quarter of 2021, Reflecting Growth of 95% to 103%Continues...

2 months ago - GlobeNewsWire

NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wi...

3 months ago - GlobeNewsWire

NEW YORK, April 15, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, Apr...

Other stocks mentioned: EGOV, LSCC, PTC, SPGI, TYL, UFS, VAR
3 months ago - PRNewsWire

When a company's return on equity ratio tops most of its competitors, it indicates the company has been very efficient in generating earnings.

Other stocks mentioned: AZN, CNNE
3 months ago - GuruFocus

Netflix and Facebook are among the top stocks for April. Q.ai's Artificial Intelligence has also dug up top tech stocks, top consumer stocks, top quality value stocks, and top growth stocks.

Other stocks mentioned: ABBV, ADBE, FB, GM, KLAC, NFLX, NKE ...
3 months ago - Forbes

As the major indices drop with fears of rising bond yields, Q.ai's Artificial Intelligence has assessed each firm to bring you today's best short plays.

Other stocks mentioned: LAUR, PINS, RDFN, ZVO
3 months ago - Forbes

Amid real potential for another sell-off, the deep learning algorithms at Q.ai have crunched the data to give you top shorts for today.

Other stocks mentioned: FTAI, FWONK, LAUR, ZVO
3 months ago - Forbes

All major indices are projected to end the week with losses, as the Dow Jones fell 70 points, the S&P 500 traded flat, and the Nasdaq mildly gained 0.2%. But Q.ai's deep learning algorithms can help y...

Other stocks mentioned: FWONK, LTHM, ROLL
4 months ago - Forbes

Progyny, a company that handles fertility benefits for other companies, managed to close out 2020 with more customers. Meanwhile, Progyny stock scored a respectable gain during the year.

4 months ago - Investors Business Daily

Growth stocks opened the day with significant losses as the 10-year yield climbed to its highest level since last January. But Q.ai's deep learning algorithms have assessed the data to bring you today's...

Other stocks mentioned: CALM, CVNA, FWONK, TRIP
4 months ago - Forbes

Although the Dow Jones gained 40 points, the S&P 500 fell 0.4%, and the Nasdaq dropped 1.1%. Q.ai's deep learning algorithms are here to help you make the most of this market with today's best short plays.

Other stocks mentioned: CALM, FWONK, LTHM
4 months ago - Forbes

Stocks have dropped again due to bond yields. In the meantime, Q.ai's Artificial Intelligence has assessed the data to bring you today's best short plays.

Other stocks mentioned: CALM, FTAI, FWONK, ROLL
4 months ago - Forbes

Fertility-benefits manager Progyny topped fourth-quarter estimates but gave cautious guidance late Wednesday. The post Progyny Beats As Fertility Clients Jump Amid Pandemic But Outlook Weak appeared fir...

5 months ago - Investors Business Daily

Reports Record Fourth Quarter Revenue of $100.3 MillionIssues Revenue Guidance of $520.0 to $540.0 Million for 2021, Reflecting Growth of 51% to 57%

5 months ago - GlobeNewsWire

Why these two stocks are strong buys.

Other stocks mentioned: CURI
5 months ago - The Motley Fool

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...

5 months ago - GlobeNewsWire

Two innovative small companies with scorching growth and one bargain biotech.

Other stocks mentioned: NVTA, VRTX
5 months ago - The Motley Fool

NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...

5 months ago - GlobeNewsWire

This fertility stock could have serious long-term potential.

6 months ago - The Motley Fool

Nio, BlackBerry, Tilray, Five9 and Progyny were our top stock trades for Tuesday. Let's check out the charts after a long holiday weekend.

Other stocks mentioned: BB, NIO, TLRY, FIVN
6 months ago - InvestorPlace

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...

8 months ago - GlobeNewsWire

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, tod...

8 months ago - GlobeNewsWire

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States.

8 months ago - Seeking Alpha

Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Shares of Progyny (NASDAQ:PGNY) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.67% over the past year to $0.05, which were in li...

8 months ago - Benzinga

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, wil...

9 months ago - GlobeNewsWire

Pharmacy benefits manager Progyny Inc (NASDAQ: PGNY) is trading 8.22% lower on thin volume in the pre-market session on Thursday. The company disclosed in SEC form 4 that TPG Group Holdings, who are mor...

9 months ago - Benzinga

Researchers Studied Journey Level Analysis of Progression to Treatment Versus Drop Out in a Large Cohort of Patients with Access to a Defined Fertility Benefit Researchers Studied Journey Level Analysis...

9 months ago - GlobeNewsWire

There are a handful of companies with no debt in the stock market, but not all of them are worth a close look. Here are seven that are.

Other stocks mentioned: DKNG, ISRG, LULU, MNST, PINS, FSLY
9 months ago - InvestorPlace

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, ...

10 months ago - GlobeNewsWire

Progyny provides employers with fertility benefits to help their employees build families.

10 months ago - The Motley Fool

Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer

10 months ago - GlobeNewsWire

Growth stocks have been the market's biggest winners. Amid valuation concerns, these 10 stocks still have the potential for 100%-plus gains.

Other stocks mentioned: APHA, CRWD, FSLY, INMD, PINS, REAL, ROKU ...
11 months ago - InvestorPlace

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme... [Read more...]

Industry
Health Information Services
IPO Date
Oct 25, 2019
Stock Exchange
NASDAQ
Ticker Symbol
PGNY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Progyny stock is "Strong Buy." The 12-month stock price forecast is 66.33, which is an increase of 17.19% from the latest price.

Price Target
$66.33
(17.19% upside)
Analyst Consensus: Strong Buy